Infectious disease experts from Dalhousie University and University of Manitoba are joining the leading-edge research team at VIDO-InterVac on one-year secondments to collaboratively advance research and development against COVID-19.
Funding through the Canada Foundation for Innovation’s (CFI) Major Science Initiatives Fund ensures Canada’s large, national research facilities have the support needed to operate and stay on the leading edge of research.
Scientists from VIDO-InterVac and Temple University in Philadelphia, Penn., have demonstrated that a salmonella biofilm protein can cause autoimmune responses and arthritis in animals.
